Clinical Trial Update: A Study of a Nucleoside Sparing Regimen in HIV-1 Infected Patients With Detectable Viremia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a nucleoside-sparing regimen in HIV-1 infected patients with detectable viremia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: Castagna Antonella | Conditions: HIV-1 Infection | Phase 2 | Status: COMPLETED